From Pre-Clinical Studies to Clinical Trials: Generation of Novel Therapies for Pregnancy Complications
Complications of pregnancy represent a significant disease burden, with both immediate and lasting consequences for mother and baby. Two key pregnancy complications, fetal growth restriction (FGR) and preeclampsia (PE), together affect around 10%–15% of all pregnancies worldwide. Despite this high i...
Main Authors: | Elizabeth C. Cottrell, Colin P. Sibley |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/16/6/12907 |
Similar Items
-
Maternal Blood Concentration of Tadalafil and Uterine Blood Flow in Pregnancy
by: Hiroaki Tanaka, et al.
Published: (2019-10-01) -
Relaxation Therapy on Fetal Outcomes in Complicated Pregnancies Suffering Sleep Disorders: A Randomized Clinical Trial
by: azar nematollahi, et al.
Published: (2016-10-01) -
Are Twin Pregnancies Complicated by Weight Discordance or Fetal Growth Restriction at Higher Risk of Preeclampsia?
by: Veronica Giorgione, et al.
Published: (2020-10-01) -
The application of aspirin in pregnancy-related complications
by: Lu-Yu Ruan, et al.
Published: (2020-01-01) -
Thrombophilia and Pregnancy Complications
by: Louise E. Simcox, et al.
Published: (2015-11-01)